A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on: February 20,2024

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on:February 20,2024

Scientists develop new model for ovarian cancer, with crossover to uterine cancer

by Leslie Cantu,Medical University of South CarolinaAlexandra Blackman, M.D., was a gynecologic oncology fellow in the lab of Joe Delaney, Ph.D., right, at the time of this photo. She is first a

Updated on: November 11,2024

Scientists develop new model for ovarian cancer, with crossover to uterine cancer

by Leslie Cantu,Medical University of South CarolinaAlexandra Blackman, M.D., was a gynecologic oncology fellow in the lab of Joe Delaney, Ph.D., right, at the time of this photo. She is first a

Updated on:November 11,2024

Addition of metastasis-directed therapy increases PFS in prostate cancer

by Elana GotkineThe addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival

Updated on: January 21,2024

Addition of metastasis-directed therapy increases PFS in prostate cancer

by Elana GotkineThe addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival

Updated on:January 21,2024

Population scientist identifies rapid rise in cervical cancer in millennial women

byMedical University of South CarolinaHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease

Updated on: January 02,2024

Population scientist identifies rapid rise in cervical cancer in millennial women

byMedical University of South CarolinaHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease

Updated on:January 02,2024

Regulation and potential drug targets of tumor-associated Tregs

by Science China PressRegulatory T cells (Tregs) negatively regulate the antitumour immune responses by inhibiting the function of effector T cells (CTL) and antigen presenting cells (APC). Credi

Updated on: April 07,2024

Regulation and potential drug targets of tumor-associated Tregs

by Science China PressRegulatory T cells (Tregs) negatively regulate the antitumour immune responses by inhibiting the function of effector T cells (CTL) and antigen presenting cells (APC). Credi

Updated on:April 07,2024

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on: June 28,2024

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on:June 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on: June 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on:June 28,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on: March 30,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on:March 30,2024

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on: January 02,2024

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on:January 02,2024

New research explores policies on timely breast cancer diagnosis for underserved women

by University of Illinois at ChicagoCredit: CC0 Public DomainA new study from University of Illinois at Chicago researchers suggests delays in diagnosis and use of under-resourced health centers

Updated on: March 08,2024

New research explores policies on timely breast cancer diagnosis for underserved women

by University of Illinois at ChicagoCredit: CC0 Public DomainA new study from University of Illinois at Chicago researchers suggests delays in diagnosis and use of under-resourced health centers

Updated on:March 08,2024

Researchers discover new molecular driver of retinoblastoma

byUT Southwestern Medical CenterInactive remnant of retinoblastoma tumor following successful intra-arterial chemotherapy. Credit: UT Southwestern Medical CenterDespite decades of medical advanc

Updated on: January 30,2024

Researchers discover new molecular driver of retinoblastoma

byUT Southwestern Medical CenterInactive remnant of retinoblastoma tumor following successful intra-arterial chemotherapy. Credit: UT Southwestern Medical CenterDespite decades of medical advanc

Updated on:January 30,2024

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on: December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on:December 28,2023